Literature DB >> 28509249

Renal cell carcinoma presenting as AA amyloidosis: a case report and review of the literature.

Adarsh Babu1, Helen Lachmann2, Tom Pickett3, Preetham Boddana3, Linmarie Ludeman4.   

Abstract

A 47-year-old Caucasian man developed mild diarrhoea associated with more than 10 kg weight loss, severe fatigue and anaemia. Endoscopy demonstrated deposits of AA amyloid within the gastrointestinal tract. He had heavy proteinuria with a serum albumin of 15 g/L consistent with systemic AA amyloidosis. He had no symptoms to suggest an underlying chronic inflammatory condition but had CRP 130 mg/L and SAA 474 mg/L. In an attempt to identify the source of his inflammatory response, he underwent a contrast-enhanced whole-body computed tomography scan, which revealed a necrotising mass lesion in the right kidney consistent with a renal cell carcinoma. It also showed non-mechanical obstruction of the small bowel and, immediately post-imaging, the patient developed intractable vomiting followed by oliguric renal failure requiring haemodialysis. Despite his renal and gut failure, he underwent right radical nephrectomy without further complications. Histology showed complete resection of a clear cell renal cell carcinoma and renal amyloid deposits. Post-surgery, his acute-phase response decreased to normal, consistent with the renal cell carcinoma acting as the inflammatory stimulus. Although he remains dialysis dependent, his gut function improved and he has regained both normal weight and serum albumin. Our case demonstrates partial resolution of AA amyloidosis with removal of the inflammatory source.

Entities:  

Keywords:  AA amyloidosis; Nephrotic syndrome; Renal cell carcinoma

Year:  2013        PMID: 28509249      PMCID: PMC5413676          DOI: 10.1007/s13730-013-0088-8

Source DB:  PubMed          Journal:  CEN Case Rep        ISSN: 2192-4449


  22 in total

1.  Renal failure and nephrotic syndrome associated with gastrointestinal stromal tumour (GIST)-a rare cause of AA amyloidosis.

Authors:  H Jaakkola; T Törnroth; P H Groop; E Honkanen
Journal:  Nephrol Dial Transplant       Date:  2001-07       Impact factor: 5.992

2.  Clinical outcome and survival of secondary (AA) amyloidosis.

Authors:  F Tanaka; K Migita; S Honda; T Fukuda; M Mine; T Nakamura; S Yamasaki; H Ida; A Kawakami; T Origuchi; K Eguchi
Journal:  Clin Exp Rheumatol       Date:  2003 May-Jun       Impact factor: 4.473

3.  Two distinct clinical courses of renal involvement in rheumatoid patients with AA amyloidosis.

Authors:  Hiroshi Uda; Akira Yokota; Kumiko Kobayashi; Tadao Miyake; Hiroaki Fushimi; Akira Maeda; Osamu Saiki
Journal:  J Rheumatol       Date:  2006-08       Impact factor: 4.666

4.  Association of serum amyloid A protein and peptide fragments with prognosis in renal cancer.

Authors:  S L Wood; M Rogers; D A Cairns; A Paul; D Thompson; N S Vasudev; P J Selby; R E Banks
Journal:  Br J Cancer       Date:  2010-06-08       Impact factor: 7.640

5.  A phase I/II study of siltuximab (CNTO 328), an anti-interleukin-6 monoclonal antibody, in metastatic renal cell cancer.

Authors:  J-F Rossi; S Négrier; N D James; I Kocak; R Hawkins; H Davis; U Prabhakar; X Qin; P Mulders; B Berns
Journal:  Br J Cancer       Date:  2010-08-31       Impact factor: 7.640

6.  Systemic amyloidosis associated with pleomorphic sarcoma of the spleen and remission of nephrotic syndrome after removal of the tumor.

Authors:  Irfan Agha; Robert Mahoney; Michael Beardslee; Helen Liapis; Randy G Cowart; Irmantas Juknevicius
Journal:  Am J Kidney Dis       Date:  2002-08       Impact factor: 8.860

7.  Results, principles and pitfalls in the management of renal AA-amyloidosis; a 10-21 year followup of 16 patients with rheumatic disease treated with alkylating cytostatics.

Authors:  K Berglund; H Thysell; C Keller
Journal:  J Rheumatol       Date:  1993-12       Impact factor: 4.666

8.  Correlation of persistently high serum amyloid A protein and C-reactive protein concentrations with rapid progression of secondary amyloidosis.

Authors:  H M Falck; C P Maury; A M Teppo; O Wegelius
Journal:  Br Med J (Clin Res Ed)       Date:  1983-04-30

9.  Natural history and outcome in systemic AA amyloidosis.

Authors:  Helen J Lachmann; Hugh J B Goodman; Janet A Gilbertson; J Ruth Gallimore; Caroline A Sabin; Julian D Gillmore; Philip N Hawkins
Journal:  N Engl J Med       Date:  2007-06-07       Impact factor: 91.245

10.  Degradation of serum amyloid A protein by surface-associated enzymes of human blood monocytes.

Authors:  G Lavie; D Zucker-Franklin; E C Franklin
Journal:  J Exp Med       Date:  1978-10-01       Impact factor: 14.307

View more
  2 in total

1.  Cervical cancer of the uterus complicated by renal AA amyloidosis.

Authors:  Hajime Fujisawa; Atsuki Ohashi; Jun Ohta; Naohiro Muraki; Yuta Nakano; Kouhei Sugita; Saori Ishihara; Jiro Kumagai; Toshiyuki Fukutomi; Kiyotaka Nagahama
Journal:  CEN Case Rep       Date:  2020-09-10

2.  Rapid clinical improvement of amyloid A amyloidosis following treatment with tocilizumab despite persisting amyloid deposition: a case report.

Authors:  Akira Yamagata; Takahiro Uchida; Yuji Yamada; Takashi Nakanishi; Kazue Nagai; Toshihiko Imakiire; Naoki Oshima; Hiroo Kumagai
Journal:  BMC Nephrol       Date:  2017-12-29       Impact factor: 2.388

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.